GS
GenSight Biologics S.A.
GSGTF · OTC
$0.09 +0.00% (+$0.00)
Market Cap 12.9M €
P/E Ratio -
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 12,902.00x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 92.71%
EPS growth N/A
FCF growth N/A
Profitability
22 /100
Weak Gross margin 100.10%
Net margin 1,204,350.00%
Op. margin 1,171,230.00%
Quality
57 /100
Average ROIC 1,518.79%
ROA 145.79%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.39x
Int. coverage -11.86x
Debt/Equity N/A
Stability
46 /100
Moderate Beta 0.70x
Rev. volatility 59.45%
EPS volatility 30.20%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GSGTF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Laurence Rodriguez
Employees
13
Headquarters
Paris
Upcoming events
29 SEP
Earnings
Upcoming earnings report